SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-003019
Filing Date
2020-03-23
Accepted
2020-03-23 16:22:41
Documents
73
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 10-K bpmx-20200131x10k.htm 10-K 2734238
2 EX-4.18 bpmx-20200131ex418efc004.htm EX-4.18 35000
3 EX-21.1 bpmx-20200131ex211ece4e8.htm EX-21.1 1984
4 EX-23.1 bpmx-20200131ex2318fe4d9.htm EX-23.1 3462
5 EX-31.1 bpmx-20200131ex311433cb7.htm EX-31.1 19102
6 EX-31.2 bpmx-20200131ex312bf0888.htm EX-31.2 19564
7 EX-32.1 bpmx-20200131ex321c69c19.htm EX-32.1 10235
8 EX-32.2 bpmx-20200131ex322a13a4c.htm EX-32.2 10281
9 GRAPHIC bpmx20200131x10k001.jpg GRAPHIC 86721
  Complete submission text file 0001558370-20-003019.txt   7885117

Data Files

Seq Description Document Type Size
10 EX-101.INS bpmx-20200131.xml EX-101.INS 1356439
11 EX-101.SCH bpmx-20200131.xsd EX-101.SCH 49172
12 EX-101.CAL bpmx-20200131_cal.xml EX-101.CAL 49809
13 EX-101.DEF bpmx-20200131_def.xml EX-101.DEF 208437
14 EX-101.LAB bpmx-20200131_lab.xml EX-101.LAB 428427
15 EX-101.PRE bpmx-20200131_pre.xml EX-101.PRE 379921
Mailing Address 900 E. HAMILTON AVE. SUITE 100 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVE. SUITE 100 CAMPBELL CA 95008 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-K | Act: 34 | File No.: 001-37411 | Film No.: 20735148
SIC: 2834 Pharmaceutical Preparations